- If approved, terlipressin would be the first FDA-approved treatment in the United States for adult patients with HRS-1, a life-threatening condition -
- Prescription Drug User Fee Act (PDUFA) target action date is September 12 -
PR Newswire
DUBLIN, July 15, 2020